The Stanley Foundation Bipolar Network: 2. Preliminary summary of demographics, course of illness and response to novel treatments
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The Stanley Foundation Bipolar Network (SFBN) evaluates treatments, course and clinical and neurobiological markers of response in bipolar illness. Aims: To give a preliminary summary of emerging findings in these areas. Method: Studies with established and potentially antimanic, antidepressant and mood-stabilising agents range from open case series to double-blind randomised clinical trials, and use the same core assessment methodology, thereby optimising the comparability of the outcomes. The National Institute of Mental Health Life Chart Method is the core instrument for retrospective and prospective longitudinal illness description. Results: The first groups of patients enrolled show a considerable degree of past and present symptomatology, psychiatric comorbidity and functional impairment. There are associations of both genetic and early environmental factors with more severe courses of illness. Open case series with add-on olanzapine, lamotrigine, gabapentin or topiramate show a differential spectrum of effectiveness in refractory patients. Conclusions: The SFBN provides important new data for the understanding and treatment of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members
Lish, J. D., Dime-Meenan, S., Whybrow, P. C., Price, R. A., & Hirschfeld, R. M. A. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90104-x · Cited by 897
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Self-citationSubstance Abuse and Bipolar Affective Disorder
SONNE, S. C., BRADY, K. T., & MORTON, W. A. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199406000-00007 · Cited by 211
Cited by
Psychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502
“Despite evidence suggesting that substance use follows bipolar disorder (8), the directionality remains uncertain (2,12).”
BackgroundThe Stanley Foundation Bipolar Treatment Outcome Network
Suppes, T., Leverich, G. S., Keck, P. E., Nolen, W. A., Denicoff, K. D., Altshuler, L. L., McElroy, S. L., Rush, A. J., Kupka, R., Frye, M. A., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00432-3 · Cited by 484
Self-citationPost, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0610 · Cited by 418
Self-citationLeverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., McElroy, S. L., Denicoff, K. D., Obrocea, G., Nolen, W. A., Kupka, R., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0503 · Cited by 352
Self-citationClinical and therapeutic implications of predominant polarity in bipolar disorder
Colom, F., Vieta, E., Daban, C., Pacchiarotti, I., & Sánchez-Moreno, J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.032 · Cited by 301
The Poor Prognosis of Childhood-Onset Bipolar Disorder
Leverich, G. S., Post, R. M., Keck, P. E., Altshuler, L. L., Frye, M. A., Kupka, R. W., Nolen, W. A., Suppes, T., McElroy, S. L., Grunze, H., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.10.070 · Cited by 253
Self-citationBipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00561.x · Cited by 200
Self-citationPattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of Mania
Swann, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00390-6 · Cited by 137
“…from controlled studies that olanzapine (Tohen et al. 1999, 2000) or risperidone (Segal et al. 1998) are effective in manic episodes regardless of the presence of psychotic or mixed features, and that they may enhance response when added to lithium or divalproex (Kupka et al. 2001; Ghaemi 2000).”
BackgroundFRIEDLANDER, A. H., FRIEDLANDER, I. K., & MARDER, S. R. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0362 · Cited by 41
Prevalence of bipolar disorder in a HIV-infected outpatient population
de Sousa Gurgel, W., da Silva Carneiro, A. H., Barreto Rebouças, D., Negreiros de Matos, K. J., do Menino Jesus Silva Leitão, T., de Matos e Souza, F. G., & Affective Disorders Study Group (GETA) (2013) · AIDS Care · doi:10.1080/09540121.2013.779625 · Cited by 31
Metadata
- Authors
- Kupka, R. W., Nolen, W. A., Altshuler, L. L., Frye, M. A., Denicoff, K. D., Leverich, G. S., Post, R. M., Keck, P. E., McElroy, S. L., Rush, A. J., & Suppes, T.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-06
- Volume
- 178
- Issue
- S41
- Pages
- s177-s183
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W3083189638
- Cited by
- 49
- References
- 4
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.